Get started
Author

Hari Krishnareddy Rachamala

Neuropilin-1: A Multifaceted Target for Cancer Therapy
2025 · Sai Manasa Varanasi, Yash Gulani, et al. · Current Oncology · 23
Dual drug-loaded tumor-targeted polymeric nanoparticles for enhancing therapeutic response in pancreatic ductal adenocarcinoma
2024 · Naga Malleswara Rao Nakka, Hari Krishnareddy Rachamala, et al. · Materials Today Bio · 19
Circulating Tumor DNA and Tissue Testing for Pancreatobiliary Tumors
2025 · Himil Mahadevia, Umair Majeed, et al. · JAMA Network Open · 8
PDF
Targeting Glioblastoma Stem Cells: Therapeutic Strategies and Clinical Perspectives
2026 · Harikrishna Reddy Rachamala, Sonia Devi Lourembam, et al. · Cancers · 6
PDF
Surface-engineered dual drug-loaded tumor-targeted liposomal nanoparticles to overcome the therapeutic resistance in glioblastoma multiforme
2026 · Ramcharan Singh Angom, Hari Krishnareddy Rachamala, et al. · Communications Medicine · 5
PDF
Strategic trimodal therapy enhances radiation-induced abscopal response in renal cancer
2025 · Hari Krishnareddy Rachamala, Naga Malleswara Rao Nakka, et al. · Journal of Translational Medicine · 5
Structural and Functional Perspectives of Optineurin in Autophagy, Immune Signaling, and Cancer
2025 · Gianluca Medigovic, Hari Krishnareddy Rachamala, et al. · Cells · 3
PDF
Multiplexed RNAs in lipid nanoparticles: potential therapeutic vaccine for chronic hepatitis B
2024 · Hari Krishnareddy Rachamala, Srujan Marepally · Signal Transduction and Targeted Therapy · 3
PDF
Lipid Nanoparticle-Mediated RNAi Against GIPC1 Overcomes Chemoresistance in Pancreatic Ductal Adenocarcinoma
2025 · Vijay Sagar Madamsetty, Hari Krishnareddy Rachamala, et al. · Pharmaceutics · 2
PDF
The endosomal escape problem solved? New insights into lipid nanoparticle delivery efficiency
2026 · Hari Krishnareddy Rachamala, Ramcharan Singh Angom, et al. · Materials Today · 1
Liver‐Specific Biocompatible Lipid Nanoparticle‐Enabled mRNA Therapy for Haemophilia B
2025 · Porkizhi Arjunan, Hari Krishnareddy Rachamala, et al. · Advanced Healthcare Materials · 1
PDF
Reply
2025 · Hari Krishnareddy Rachamala, Krishnendu Pal, et al. · Gastroenterology · 1
Recent Advances in Lipid Nanoparticles for Cancer Vaccines: From Antigen Delivery to Personalized Immunotherapy
2026 · Hari Krishnareddy Rachamala, Ramcharan Singh Angom, et al. · International Journal of Molecular Sciences
Targeted delivery platforms for in vivo immune cell engineering: emerging strategies for cancer immunotherapy
2026 · Hari Krishnareddy Rachamala, Sandeep Atla, et al. · Frontiers in Pharmacology
PDF
Author Correction: Surface-engineered dual drug-loaded tumor-targeted liposomal nanoparticles to overcome the therapeutic resistance in glioblastoma multiforme
2026 · Ramcharan Singh Angom, Hari Krishnareddy Rachamala, et al. · Communications Medicine
PDF
AI-driven discovery and validation of a GIPC1 PDZ domain inhibitor for pancreatic ductal adenocarcinoma
2026 · Hari Krishnareddy Rachamala, Naga Malleswara Rao Nakka, et al. · Cell Reports
Multifunctional nano-vaccines integrating lipid-conjugated tumor antigens with TLR/STING agonists enhance cancer immunotherapy
2026 · Hari Krishnareddy Rachamala, Naga Malleswara Rao Nakka, et al. · Cancer Letters
Correction: Vascular endothelial growth factor receptor-1 (VEGFR-1) knock-down is protective against hypoxia, Aβ1-42 oligomer and Aβ1-42 fibril-induced neuronal cell death: implications in AD pathogenesis
2026 · Ramcharan Singh Angom, Zonghua Li, et al. · Frontiers in Neuroscience
PDF
Vascular endothelial growth factor receptor-1 (VEGFR-1) knock-down is protective against hypoxia, Aβ1-42 oligomer and Aβ1-42 fibril -induced neuronal cell death: implications in AD pathogenesis
2026 · Ramcharan Singh Angom, Zonghua Li, et al. · Frontiers in Neuroscience
Amphiphilic Glycopolymer Nanoparticles for pH-Responsive Paclitaxel Delivery and Enhanced Efficacy in Pancreatic Ductal Adenocarcinoma Therapy
2026 · Naga Malleswara Rao Nakka, Hari Krishnareddy Rachamala, et al. · ACS Applied Bio Materials
Combining Tumor Treating Fields with Immunotherapy in Pancreatic Ductal Adenocarcinoma: Mechanisms, Preclinical Evidence, and Emerging Therapeutic Synergy
2026 · Douaa Albelal, Hari Krishnareddy Rachamala, et al. · Cells
PDF
Abstract 5842: Combined KRAS pathway inhibition and ONIOYID treatment enhances tumor regression, attenuates desmoplasia, and augments T cell infiltration in pancreatic ductal adenocarcinoma
2026 · Hari Krishnareddy Rachamala, Fang Wei, et al. · Cancer Research
Tumor-targeted Butein-loaded PLGA nanoparticles improve gemcitabine sensitivity and prolong survival in pancreatic ductal adenocarcinoma
2026 · Naga Malleswara Rao Nakka, Hari Krishnareddy Rachamala, et al. · Genes & Diseases
Enhancing the fitness of NK cell via olfactory receptor OR7A10: a novel strategy to improve immune therapy for solid tumors
2026 · Hari Krishnareddy Rachamala, Purushothaman Vetrivel, et al. · Targetome
PDF
Nanotechnology-Mediated Delivery of Vaccines in COVID-19 Management
2026 · Naga Malleswara Rao Nakka, Hari Krishnareddy Rachamala, et al. · Nanomedicine and nanotoxicology
Works count: 27
Citation count: 76
H-index: 5
I10-index: 2
Year
Topic
Type